tiprankstipranks
Fresh Tracks Therapeutics, Inc. (FRTX)
:FRTX
US Market

Fresh Tracks Therapeutics (FRTX) Financial Statements

Compare
507 Followers

Fresh Tracks Therapeutics Financial Overview

Fresh Tracks Therapeutics's market cap is currently $5.59M. The company's EPS TTM is $-1.409; its P/E ratio is ―; Fresh Tracks Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 8.01M$ 6.94M$ 404.00K$ 1.82M$ 7.92M
Gross Profit$ 8.01M$ -7.10M$ -27.83M$ -9.39M$ -12.30M
Operating Income$ -6.36M$ -21.53M$ -40.24M$ -20.98M$ -24.47M
EBITDA$ -5.65M$ -21.06M$ -39.38M$ -20.90M$ -24.47M
Net Income$ -5.69M$ -20.66M$ -39.52M$ -20.90M$ -25.95M
Balance Sheet
Cash & Short-Term Investments$ 10.87M$ 8.68M$ 26.88M$ 30.11M$ 7.23M
Total Assets$ 11.59M$ 10.27M$ 29.72M$ 33.63M$ 18.14M
Total Debt$ 0.00$ 49.00K$ 69.00K$ 511.00K$ 151.00K
Net Debt$ -10.87M$ -8.63M$ -26.82M$ -29.60M$ -7.08M
Total Liabilities$ 1.66M$ 3.08M$ 4.81M$ 6.50M$ 10.57M
Stockholders' Equity$ 9.93M$ 7.19M$ 24.91M$ 27.14M$ 7.57M
Cash Flow
Free Cash Flow$ -4.34M$ -19.38M$ -36.18M$ -20.06M$ -35.99M
Operating Cash Flow$ -4.34M$ -19.34M$ -36.15M$ -20.03M$ -35.98M
Investing Cash Flow$ 0.00$ -47.00K$ -36.00K$ 4.48M$ 32.51M
Financing Cash Flow$ 6.53M$ 1.18M$ 32.95M$ 38.44M$ 2.64M
Currency in USD

Fresh Tracks Therapeutics Earnings and Revenue History

Fresh Tracks Therapeutics Debt to Assets

Fresh Tracks Therapeutics Cash Flow

Fresh Tracks Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis